TELA Bio, Inc. Common Stock
TELATELA Bio, Inc. is a biotechnology company focused on developing and commercializing novel tissue repair products derived from its proprietary decellularization and sterilization technologies. The company specializes in products designed to facilitate soft tissue repair and reconstruction, primarily in the fields of orthopedics and surgical applications. TELA aims to improve patient outcomes by providing advanced, biocompatible tissue solutions.
Company News
The global hernia repair devices market is projected to reach US$ 6.57 billion by 2033, driven by rising procedural volumes, technological advancements, and increasing adoption of minimally invasive techniques. Key trends include the shift towards mesh implants, competition between open and laparoscopic repair, and the growing use of robotic plat...
TELA Bio, a medical technology company, announced the closing of its public offering of common stock and pre-funded warrants, raising $46 million. The company plans to use the proceeds for general corporate purposes.
MALVERN, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed, a medical device technology company ...
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer. In this role, Mr. Firestone will oversee the Company�...
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units ...
